A Dose of Reality with Charles Spence7 Apr 2025

Chris Lowe, CEO at Nusano - Radioisotopes, Volunteering in Hospitals, Culture Building, and More

In this episode, I talked with Chris Lowe, CEO of Nusano, where he discusses his career journey in the medical technology field, particularly focusing on the production of medical radioisotopes. He shares insights on leadership, the importance of building a talented team, and the societal responsibilities of his company. Chris also highlights common mistakes in drug development and reflects on a case study from his past. Our conversation emphasizes the significance of patient-centric approaches in the industry.

Here's what you're in:

The highest and lowest career points of Chris’ career.
Why medical radioisotopes production is so important and how Nusano is approaching this.
Exploring mistakes that companies are still making today.

Timestamps:

04:51 Proudest Moment of Chris in his Career and Leadership Philosophy

07:41 Nusano: Innovations in Medical Radioisotope Production

13:55 Building a Talented Team at Nusano

17:57 Company Culture and Societal Responsibility

19:48 Common Mistakes Companies Are Still Making Today

22:40 Case Study: The Francis Trial

30:24 Final Thoughts on Patient-Centric Drug Development

About Chris

Chris Lowe is the CEO of Nusano, a privately-held medical technology company that specializes in the production of medical radioisotopes used for diagnosing and treating diseases such as cancer. Chris has led 5 IPOs as a C-level executive, all focused on supporting therapeutic development, while efficiently building and scaling operations.

Prior to this, he spent 3 years with Cortexyme as COO and CFO. He has over 15 years of C-Suite experience in various private and public life sciences, medical technology, and technology companies.

Connect with Chris

LinkedIn: https://www.linkedin.com/in/chrislowe7/

Company Website: https://nusano.com/

About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with me:

LinkedIn: https://www.linkedin.com/in/charles-spence-clinical/

Website: https://www.discera-search.com/

Opinions and comments expressed by the guest do not represent the company and are fully their own.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(75)

Pawel Szczepanski, CEO at JJP Biologics, on Leading Without a Science Degree, Building Culture from Day One, and Why Trust Still Wins in Biotech Fundraising

In this episode, I talked with Pawel Szczepanski, CEO of JJP Biologics, a Polish biotech developing next-generation biologics in the personalized medicine space, to hear about his path from investment...

21 Sep 40min

Eliot Forster, CEO at Levicept on 30 Years in Pharma, Running a Six-Person Biotech, and the Future of European Drug Development

In this episode, I talked with Eliot Forster, CEO of Levicept, a neurophysiologist-turned biotech veteran with 30+ years of experience across Big Pharma and a series of CEO roles. We get into clinical...

7 Sep 45min

Michael Zaiac, Medical Affairs Lead for Oncology at Daiichi Sankyo on 30 Years of Hiring Lessons, The ADC Wave, and Building Teams in a Fast-Moving Pipeline

In this episode, I talked with Michael Zaiac, Medical Affairs Lead for Oncology across Europe and Canada at Daiichi Sankyo — a trained surgical oncologist who walked away from the operating table, mov...

24 Aug 39min

Juho Jalkanen, CEO at Faron Pharmaceuticals on From Surgeon to CEO, Rethinking Boards, and Fighting for the Right Science

In this episode, I talked with Dr. Juho Jalkanen, CEO of Faron Pharmaceuticals — a publicly listed Finnish biotech building novel immunotherapies for blood cancers. Juho's path is unlike most you'll h...

10 Aug 37min

Tobias Kampfenkel, MD, MHBA, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine, on Transformative Drugs in Oncology and Autoimmunity: It's Always the Team!

In this episode, I talked with Dr. Tobias Kampfenkel, Vice President of Early Clinical Development and Translational Research at Miltenyi Biomedicine. Tobias spent nearly a decade at Janssen building ...

15 Juni 39min

Sofia Heigis, CEO of OncoPeptides, From Sales Rep to CEO, Being "Present", and Hiring for Self-Insight

In this episode, I talked with Sofia Heigis, Chief Executive Officer of OncoPeptides, about a career path that did not start where she expected. Sofia originally wanted to move into clinical operation...

31 Maj 38min

Jens Lindberg, CEO at Medivir, on The Biotech Rollercoaster - Medivir´s Previous Four Months (and Biotech Today in 2026)

In this episode, I talked with Jens Lindberg, CEO of Medivir AB, a Swedish biotech developing innovative therapies in liver cancer and rare disease. Jens brings over 30 years of late-stage development...

18 Maj 33min

Hubert Truebel, Managing Director at DEBRA Research, on Creating Own Career Opportunities...and a Practical Approach to Longevity

In this episode, I talked with Hubert Truebel, Managing Director at DEBRA Research, to discover a career that wasn’t built traditionally—but through creating opportunities where none formally existed....

4 Maj 28min